SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Colby who wrote (7092)4/15/1998 6:47:00 PM
From: blankmind  Read Replies (1) | Respond to of 23519
 
- I could be wrong -- but my advice to everyone is to be patient.

- The world's population is aging - and ED drugs are in demand.

- If Viagra proves 100% effective with no side effects - Vivus is dead in the water.

- However, if Viagra is a great drug - and proves 60% effective with some side effects - then Vivus will grow in to a $200+ mill a year; perhaps a $1 bill/year company. Stock goes to $40+. And life is good.

- That's why patience really is a virtue.



To: Colby who wrote (7092)4/15/1998 6:50:00 PM
From: Mkilloran  Read Replies (1) | Respond to of 23519
 
Stay Long....and next April 15 you too can send Uncle Sam a big check from your Vivus profits....Take a trip down to Fla and see how many Sr Citizens are running (well at least walking fast) to their Dr's asking about Viagara....soon they will learn about Muse. The population is aging ED will be a bigger market over the next 10-20 years....47 million people with ED by the year 2000.....


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News